Three studies in type 2 diabetes: ADOPT Rosiglitazone monotherapy in type 2 diabetes: what indication?

被引：0
|
作者：
Roussel, R. [1 ]
机构：
[1] CHU Bichat Claude Bernard, Serv Endocrinol Diabetol Nutr, F-75722 Paris 18, France
来源：
ANNALES D ENDOCRINOLOGIE | 2007年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S28 / S32
页数：5
相关论文
共 50 条
  • [31] Ertugliflozin as a monotherapy for the treatment of type 2 diabetes
    Hu, Jingbo
    Deng, Aiping
    Zhao, Yufen
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (16) : 1841 - 1847
  • [32] Benefits of rosiglitazone in children with type 2 diabetes mellitus
    Saenger, P
    Dabiri, G
    Jones, K
    Krebs, J
    Sun, Y
    Mudd, P
    Weston, WM
    Cobitz, AR
    Freed, MI
    Porter, LE
    DIABETOLOGIA, 2005, 48 : A53 - A53
  • [33] Repaglinide/Rosiglitazone combination therapy of type 2 diabetes
    Raskin, P
    McGill, J
    Hale, P
    Khutoryansky, N
    Santiago, O
    DIABETES, 2001, 50 : A128 - A129
  • [34] The effect of rosiglitazone on gluconeogenesis in patients with Type 2 diabetes
    Gastaldelli, A
    Miyazaki, Y
    Matsuda, M
    Pettiti, M
    Santini, E
    Ferrannini, E
    Defronzo, RA
    DIABETOLOGIA, 2002, 45 : A5 - A5
  • [35] The forgotten type 2 diabetes mellitus medicine: rosiglitazone
    Xu, Bo
    Xing, Aoxiang
    Li, Shuwei
    DIABETOLOGY INTERNATIONAL, 2022, 13 (01) : 49 - 65
  • [36] The sweet and sour RECORD of rosiglitazone for type 2 diabetes
    Reactions Weekly, 2007, 1155 (1) : 4 - 4
  • [37] Rosiglitazone, PPAR(gamma), and Type 2 Diabetes.
    Kahn, Barbara B.
    McGraw, Timothy E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (27): : 2667 - 2669
  • [38] The forgotten type 2 diabetes mellitus medicine: rosiglitazone
    Bo Xu
    Aoxiang Xing
    Shuwei Li
    Diabetology International, 2022, 13 : 49 - 65
  • [39] Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients
    Wang, Jie
    Bao, Yu-qian
    Hu, Cheng
    Zhang, Rong
    Wang, Cong-rong
    Lu, Jun-xi
    Jia, Wei-ping
    Xiang, Kun-san
    ACTA PHARMACOLOGICA SINICA, 2008, 29 (02) : 252 - 258
  • [40] Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients
    Jie Wang
    Yu-qian Bao
    Cheng Hu
    Rong Zhang
    Cong-rong Wang
    Jun-xi Lu
    Wei-ping Jia
    Kun-san Xiang
    Acta Pharmacologica Sinica, 2008, 29 : 252 - 258
12345